Thermal ablation for ata intermediate-risk papillary thyroid carcinoma: efficacy and safety outcomes in a retrospective cohort
TA shows promising efficacy and safety for selected ATA intermediate-risk PTC patients, with lymph node size as a key prognostic factor.
Authors
- Na Yu (ORCID: https://orcid.org/0000-0001-5473-7591)
- Tianhao Cong
- Miao Yu (ORCID: https://orcid.org/0000-0002-3587-2760)
- Jie Wu (ORCID: https://orcid.org/0000-0003-2137-0193)
- Lili Peng
- MD Ying Wei
- Zhenlong Zhao (ORCID: https://orcid.org/0000-0001-9640-8921)
- Han-xiao Zhao
- Yan Li
- Shi-liang Cao
- Xin-yi Zhou
Institutions
- Beijing University of Chinese Medicine (CN)
- China-Japan Friendship Hospital (CN)
Publication Details
- Journal
- Frontiers in Endocrinology
- Published
- 2025-12-30
- DOI
- https://doi.org/10.3389/fendo.2025.1736498
- Primary Topic
- Thyroid Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China